Webb-Waring Center

Focused on fundamental investigation of the causes and consequences of inflammation, antioxidant deficiency and oxidative stress.

The Webb-Waring Center has a long tradition. Webb-Waring is historically tied to the Colorado and world research community for the better part of a century. Originally founded by Dr. Gerald B. Webb and Dr. James J. Waring in 1924 for the study of tuberculosis, Webb-Waring focuses on innovative medical research and education.Our research is advancing understanding and improving the management of health and disease. The Webb-Waring Center’s motivated staff and investigators strive to maintain the highest standard of research excellence and to provide a high level education that inspires and prepares students for careers in biomedical research and medicine. 

Webb-Waring investigators are recognized for making the first clinical recognition of the Acute Respiratory Distress Syndrome (ARDS) and developing a commonly used diagnostic test of lung function. Currently, Webb-Waring Center investigators are actively developing new diagnostic and therapeutic approaches for ARDS, type 1 and type 2 diabetes, multiple sclerosis (MS), fatty liver, atherosclerosis, traumatic brain injury (TBI), age-related macular degeneration (AMD) and aging. 

The Webb-Waring Center relocated approximately four years ago to the new comprehensive Anschutz Medical Campus of the University of Colorado School of Medicine and Health Sciences Center in Aurora, Colorado. The Webb-Waring Center complex is located on the south end of the third floor of the School of Pharmacy. 

Please review our individual laboratories and their related research activities. Thank you for your continued interest and meaningful support of our research.

John E. Repine, MD